Integrative Cell Phenotyping Core
- Institution
- CINCINNATI CHILDRENS HOSP MED CTR, OH
- Principal investigator
- Sherry L Thornton
- Funding
- $137K
- Duration
- 2016–2028
Moonbase score
Still being scored
Abstract
Abstract – Integrative Cell Phenotyping Core (ICPC) Several cell types are involved in inflammatory processes in rheumatic diseases. Understanding the pathobiology of these diseases often requires dissecting out contributions of specific cell subpopulations. The ICPC (Integrative Cell Phenotyping Core) will provide technical expertise, assistance and equipment at a reasonable cost to investigators in the Cincinnati Rheumatic Disease Core Center (CRDCC) whose studies require single cell analysis. ICPC provides training in proper use and interpretation of a number of immunophenotyping methodologies, including flow cytometry, multiplex analyte analysis and single cell genomic, proteomic and spatial transcriptomic analysis. Expertise and assistance will be provided by Core personnel in the following areas: • High-parameter immunophenotyping (cell surface and intracellular) • Single cell gene expression analysis • Cell sorting • Gene expression reporter analysis • Cell proliferation analysis • Cell cycle and DNA content analysis • Apoptosis analysis • Intracellular calcium mobilization analysis • Tetramer staining of antigen-specific T cells • RNA detection by flow cytometry • Cell signalling analysis • CRISPR genome-edited cell identification and sorting • Imaging cytometry • Multiplex protein/analyte detection • Single cell protein secretion • Spatial transcriptomics In addition, the ICPC will facilitate acquisition, analysis and storage of immunophenotyping data, maintain standards and quality control for immunophenotyping, single cell gene expression, and spatial transcriptomics procedures, and will assist in the application and development of new techniques.
LOADING MOONBASE SCORE
Questions for CINCINNATI CHILDRENS HOSP MED CTR
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Cincinnati Childrens Hosp Med Ctr54
Sirolimus TSC Epilepsy Prevention Study (STEPS) IND#145820 11/8/2019
Martina Bebin · $651K · 2021–2027
- NIH · Cincinnati Childrens Hosp Med Ctr48
Abatacept for the treatment of Common Variable Immunodeficiency with Interstitial Lung Disease (ABCVILD) IND #152820 9/2/20
Michael Jordan · $530K · 2021–2027
- NIH · Cincinnati Childrens Hosp Med Ctr44
Molecular signaling in uterine receptivity to implantation
Xiaofei Sun · $439K · 2011–2028